Mr. King's experience will boost growth and shareholder valu...
Mr. King's experience will boost growth and shareholder value, says company. He anticipates a bright future for SAB with progress in type-1 diabetes trials and commercialization.
Press Release: SAB Biotherapeutics Appoints Michael G. King Jr. as Chief Financial Officer
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment